Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
82.58
+0.19 (0.23%)
Sep 1, 2026, 1:22 PM EDT - Market open
Arrowhead Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Cash & Equivalents | 50.66 | 224.65 | 99.19 | 102.99 | 100.71 | 184.43 |
Short-Term Investments | 1,547 | 692.82 | 578.28 | 292.74 | 268.39 | 183.36 |
Cash & Short-Term Investments | 1,598 | 917.47 | 677.46 | 395.73 | 369.1 | 367.79 |
Cash Growth | 77.90% | 35.43% | 71.19% | 7.22% | 0.36% | 16.58% |
Receivables | 18.79 | 6.82 | - | - | 1.41 | 10.26 |
Prepaid Expenses | 25.37 | 10.93 | 9.54 | 8.81 | 7.29 | 4.36 |
Restricted Cash | 4.1 | 1.9 | 3.5 | 7.9 | 7.3 | - |
Other Current Assets | 25.29 | 13.52 | 4.97 | 4.03 | 20.2 | 2.19 |
Total Current Assets | 1,671 | 950.64 | 695.47 | 416.47 | 405.3 | 384.6 |
Property, Plant & Equipment | 428.97 | 426.41 | 431.29 | 335.56 | 168.59 | 66.02 |
Long-Term Investments | 2.2 | - | - | - | 105.87 | 245.6 |
Other Intangible Assets | 5.59 | 6.86 | 8.56 | 10.26 | 11.96 | 13.66 |
Other Long-Term Assets | 3.85 | 1.39 | 4.48 | 3.26 | 0.22 | 0.27 |
Total Assets | 2,112 | 1,385 | 1,140 | 765.55 | 691.94 | 710.15 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Accounts Payable | 27.78 | 17.67 | 11.39 | 35.87 | 2.87 | 9.46 |
Accrued Expenses | 106.44 | 96.24 | 80.8 | 43.68 | 59.11 | 23.77 |
Short-Term Debt | 3.2 | 10.3 | - | - | - | - |
Current Portion of Long-Term Debt | 40 | 40 | - | - | - | - |
Current Portion of Leases | 5.32 | 7.29 | 6.34 | 10.56 | 2.78 | 2.25 |
Current Income Taxes Payable | - | 20.8 | - | - | - | - |
Current Unearned Revenue | 94.6 | 2.4 | - | 0.87 | 74.1 | 111.06 |
Other Current Liabilities | 6.02 | 0.79 | 4.64 | 14.48 | - | - |
Total Current Liabilities | 283.35 | 195.49 | 103.17 | 105.46 | 138.85 | 146.54 |
Long-Term Debt | 1,217 | 582.28 | 734.54 | 268.33 | - | - |
Long-Term Leases | 114.3 | 104.11 | 111.03 | 104.61 | 78.8 | 23.3 |
Long-Term Unearned Revenue | 31.74 | - | - | - | 55.95 | 131.5 |
Total Liabilities | 1,646 | 881.88 | 948.74 | 478.39 | 273.6 | 301.33 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Common Stock | 0.24 | 0.23 | 0.22 | 0.2 | 0.2 | 0.2 |
Additional Paid-In Capital | 2,443 | 2,140 | 1,806 | 1,300 | 1,219 | 1,053 |
Retained Earnings | -1,923 | -1,627 | -1,626 | -1,026 | -820.76 | -644.69 |
Treasury Stock | -53.19 | -53.19 | - | - | - | - |
Comprehensive Income & Other | -1.23 | 6.44 | 4.75 | -3.22 | -0.14 | -0.07 |
Total Common Equity | 465.53 | 466.05 | 185.44 | 271.34 | 398.52 | 408.82 |
Minority Interest | 0.51 | 37.36 | 5.62 | 15.82 | 19.82 | - |
Shareholders' Equity | 466.04 | 503.42 | 191.06 | 287.16 | 418.34 | 408.82 |
Total Liabilities & Equity | 2,112 | 1,385 | 1,140 | 765.55 | 691.94 | 710.15 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Total Debt | 1,379 | 743.98 | 851.91 | 383.5 | 81.58 | 25.55 |
Net Cash (Debt) | 218.46 | 173.49 | -174.45 | 12.23 | 287.52 | 342.24 |
Net Cash Growth | 22.88% | - | - | -95.75% | -15.99% | 16.27% |
Net Cash Per Share | 1.56 | 1.30 | -1.46 | 0.11 | 2.73 | 3.30 |
Filing Date Shares Outstanding | 141.25 | 135.81 | 124.43 | 107.43 | 106.01 | 104.53 |
Total Common Shares Outstanding | 141.14 | 135.7 | 124.38 | 107.31 | 105.96 | 104.33 |
Working Capital | 1,388 | 755.15 | 592.3 | 311.02 | 266.45 | 238.06 |
Book Value Per Share | 3.30 | 3.43 | 1.49 | 2.53 | 3.76 | 3.92 |
Tangible Book Value | 459.94 | 459.19 | 176.88 | 261.08 | 386.56 | 395.16 |
Tangible Book Value Per Share | 3.26 | 3.38 | 1.42 | 2.43 | 3.65 | 3.79 |
Land | 3 | 3 | 3 | 3 | 3 | - |
Buildings | 254.86 | 251.32 | 75.99 | - | - | - |
Machinery | 102.41 | 88 | 71.93 | 58.75 | 40.47 | 29.67 |
Construction In Progress | 5.81 | 15.94 | 188.73 | 166.66 | 56.37 | 0.35 |
Leasehold Improvements | 104.46 | 104.43 | 104.41 | 103.81 | 42.02 | 41.52 |